| Arachidonoyl serotonin | |
|---|---|
|
(5Z,8Z,11Z,14Z)-N-(2-(5-hydroxy-1H-indol-3-yl)ethyl)icosa-5,8,11,14-tetraenamide |
|
|
Other names
N-arachidonoyl-serotonin |
|
| Identifiers | |
| CAS number | 187947-37-1 |
| PubChem | 10027372 |
| ChemSpider | 8202943 |
| ChEMBL | CHEMBL191534 |
| Jmol-3D images | Image 1 |
|
|
|
|
| Properties | |
| Molecular formula | C30H42N2O2 |
| Molar mass | 462.67 g mol−1 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references | |
Arachidonoyl serotonin (N-arachidonoyl-serotonin, AA-5-HT) is an endogenous lipid signaling molecule. It was first described in 1998 as being an inhibitor of fatty acid amide hydrolase (FAAH).[1] In 2007, it was shown to have analgesic properties and to act as an antagonist of the TRPV1 receptor.[2] In 2011, it was shown to be present in the ileum and jejunum of the gastrointestinal tract and modulate glucagon-like peptide-1 (GLP-1) secretion.[3]
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)